Overview
Mycetoma caused by Madurella grisea is a chronic, granulomatous infection characterized by localized swelling, draining sinuses, and the formation of distinctive grains in the affected tissue, typically involving the skin and underlying structures of the extremities. This condition predominantly affects individuals in rural agricultural settings, particularly in tropical and subtropical regions, with a notable predilection for men aged 20 to 50 years who engage in activities exposing their limbs to soil and vegetation. Early diagnosis and intervention are crucial due to the progressive nature of the disease, which can lead to significant functional impairment if left untreated. Understanding the clinical presentation and prompt management are essential for clinicians to mitigate long-term disability and improve patient outcomes 15.Pathophysiology
Madurella grisea infection initiates with traumatic implantation of fungal spores into the skin, often through minor injuries. The fungus then invades the subcutaneous tissues, leading to a chronic inflammatory response characterized by the formation of granulomas. These granulomas evolve into characteristic "grains," which are aggregates of fungal cells surrounded by inflammatory cells and host tissue debris. The continuous proliferation of these grains and the associated inflammatory reaction cause progressive tissue destruction, leading to the hallmark clinical features of mycetoma, including painless swelling, sinus tract formation, and the discharge of black or white grains. Molecularly, the pathogenicity of M. grisea involves its ability to evade host immune responses and manipulate cellular signaling pathways, contributing to its persistence and the chronic nature of the infection 5.Epidemiology
Mycetoma caused by Madurella grisea has a global distribution but is most prevalent in tropical and subtropical regions, particularly in Africa, India, and Central and South America. The exact incidence is challenging to determine due to underreporting and diagnostic challenges, but it is estimated to affect thousands annually. The disease predominantly affects young to middle-aged adults, with a male-to-female ratio often exceeding 10:1, reflecting occupational exposures. Risk factors include agricultural activities, manual labor involving soil contact, and poor wound care practices. Over time, there has been a gradual increase in reported cases linked to improved awareness and diagnostic capabilities, though regional disparities persist 15.Clinical Presentation
Patients typically present with painless swelling in the affected limb, often starting at the site of initial trauma. Over time, the swelling becomes more pronounced and may be associated with the development of multiple sinuses that discharge characteristic grains, which can be black (indicative of Madurella species) or white (suggestive of other causative agents like Actinomadura or Nocardia). Pain is usually minimal initially but can increase as the disease progresses and involves deeper structures such as bones and tendons. Red-flag features include rapid progression, systemic symptoms like fever, and involvement of vital structures, which necessitate urgent referral for comprehensive management 5.Diagnosis
The diagnosis of mycetoma caused by Madurella grisea involves a combination of clinical evaluation and laboratory investigations. Key steps include:Management
First-Line Treatment
Second-Line Treatment
Refractory or Specialist Escalation
Complications
Prognosis & Follow-up
The prognosis for mycetoma caused by Madurella grisea varies widely depending on the extent of disease at diagnosis and the timeliness and efficacy of treatment. Early intervention significantly improves outcomes, reducing the risk of severe deformities and functional impairment. Prognostic indicators include the absence of bone involvement at diagnosis and successful eradication of the fungus. Recommended follow-up intervals include:Special Populations
Key Recommendations
References
1 Liu L, Li Q, Alami M, Shen R, Zhu J, Zhang Q et al.. Comparison of metabolite differences and pharmacologically active constituents between Piper longum and Piper sarmentosum based on non-targeted metabolomics. PeerJ 2026. link 2 Gu RR, Meng XH, Zhang Y, Xu HY, Zhan L, Gao ZB et al.. (-)-Naringenin 4',7-dimethyl Ether Isolated from . Molecules (Basel, Switzerland) 2022. link 3 Baydoun E, Bano S, Atia-tul-Wahab, Jabeen A, Yousuf S, Mesaik A et al.. Fungal transformation and T-cell proliferation inhibitory activity of melengestrol acetate and its metabolite. Steroids 2014. link 4 McVaugh M. Richard Wiseman and the medical practitioners of restoration London. Journal of the history of medicine and allied sciences 2007. link 5 Sulaiman MR, Somchit MN, Israf DA, Ahmad Z, Moin S. Antinociceptive effect of Melastoma malabathricum ethanolic extract in mice. Fitoterapia 2004. link